Quest Diagnostics reaffirmed as a buy: organic growth, macro demand, strong margins, investment-grade ratings, and dividend ...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been named to the Fortune® magazine 2026 World's Most Admired Companies™ list, for the ...
SOUTHFIELD, Mich. and GRAND RAPIDS, Mich. and SECAUCUS, N.J., Jan. 5, 2026 /PRNewswire/ -- Corewell Health and Quest Diagnostics (NYSE: DGX) today announced the completion of the previously announced ...
Southfield, Mich.-based Corewell Health and Secaucus, N.J.-based Quest Diagnostics have finalized a lab joint venture and hospital lab management agreement. Five things to know: 1. The new joint ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Quest Diagnostics handles the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. It’s not an easy time to lead a health system. A recent ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. The Meta Quest 3S is an ...
Hims & Hers—the virtual care platform with about 2.5 million subscribers—will now offer laboratory testing through Quest Diagnostics. Customers will have access to more than 120 biomarker tests across ...
Quest Diagnostics Incorporated announced its Q3 earnings yesterday - revenues year-to-date are $8.23bn, and net income $845m. DGX is finally demonstrating a strong post-pandemic recovery, with Q3 ...
Quest Diagnostics (NASDAQ:DGX) posted better-than-expected earnings for the third quarter on Tuesday. While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the ...
What To Know: While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the company lowered its GAAP earnings per share guidance to a range of $8.58 to $8.66 from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results